Channing Global Advisors, LLC Astrazeneca PLC Transaction History
Channing Global Advisors, LLC
- $105 Million
- Q3 2024
A detailed history of Channing Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Channing Global Advisors, LLC holds 5,864 shares of AZN stock, worth $377,876. This represents 0.43% of its overall portfolio holdings.
Number of Shares
5,864
Previous 6,548
10.45%
Holding current value
$377,876
Previous $510,000
10.59%
% of portfolio
0.43%
Previous 0.49%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.05 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.71 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.4 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.37 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.23 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...